MOYER CHARLES 4
4 · KING PHARMACEUTICALS INC · Filed Jun 3, 2010
Insider Transaction Report
Form 4
MOYER CHARLES
Director
Transactions
- Sale
Common Stock
2010-06-01$8.57/sh−7,000$59,990→ 32,213 total
Footnotes (2)
- [F1]This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 3, 2010.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.52 to $8.611, inclusive. The reporting person has provided to King Pharmaceuticals, Inc., and will provide upon request to any security holder of King Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.